These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1032 related articles for article (PubMed ID: 25579867)

  • 1. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
    Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
    Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of olanzapine and methyl-β-cyclodextrin complexes using a single-step, organic solvent-free supercritical fluid process: An approach to enhance the solubility and dissolution properties.
    Rudrangi SR; Trivedi V; Mitchell JC; Wicks SR; Alexander BD
    Int J Pharm; 2015 Oct; 494(1):408-16. PubMed ID: 26315120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid-state flurbiprofen and methyl-β-cyclodextrin inclusion complexes prepared using a single-step, organic solvent-free supercritical fluid process.
    Rudrangi SR; Kaialy W; Ghori MU; Trivedi V; Snowden MJ; Alexander BD
    Eur J Pharm Biopharm; 2016 Jul; 104():164-70. PubMed ID: 27163245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of budesonide- and indomethacin-hydroxypropyl-beta-cyclodextrin (HPBCD) complexes using a single-step, organic-solvent-free supercritical fluid process.
    Bandi N; Wei W; Roberts CB; Kotra LP; Kompella UB
    Eur J Pharm Sci; 2004 Oct; 23(2):159-68. PubMed ID: 15451004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase solubility and inclusion complex of itraconazole with beta-cyclodextrin using supercritical carbon dioxide.
    Al-Marzouqi AH; Shehatta I; Jobe B; Dowaidar A
    J Pharm Sci; 2006 Feb; 95(2):292-304. PubMed ID: 16372306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of dissolution amount and in vivo bioavailability of itraconazole by complexation with beta-cyclodextrin using supercritical carbon dioxide.
    Hassan HA; Al-Marzouqi AH; Jobe B; Hamza AA; Ramadan GA
    J Pharm Biomed Anal; 2007 Oct; 45(2):243-50. PubMed ID: 17630246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of supercritical fluid technology as preparative technique of benzocaine-cyclodextrin complexes--comparison with conventional methods.
    Al-Marzouqi AH; Jobe B; Dowaidar A; Maestrelli F; Mura P
    J Pharm Biomed Anal; 2007 Jan; 43(2):566-74. PubMed ID: 17010552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
    Jug M; Maestrelli F; Bragagni M; Mura P
    J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity.
    Salústio PJ; Feio G; Figueirinhas JL; Pinto JF; Cabral Marques HM
    Eur J Pharm Biopharm; 2009 Feb; 71(2):377-86. PubMed ID: 18977436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of ibuprofen/beta-cyclodextrin complexes obtained by supercritical carbon dioxide and other conventional methods.
    Hussein K; Türk M; Wahl MA
    Pharm Res; 2007 Mar; 24(3):585-92. PubMed ID: 17260160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of mosapride citrate inclusion complexes with natural and synthetic cyclodextrins.
    Ali AA; Sayed OM
    Pharm Dev Technol; 2013; 18(5):1042-50. PubMed ID: 22206481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preformulation study of the inclusion complex warfarin-beta-cyclodextrin.
    Zingone G; Rubessa F
    Int J Pharm; 2005 Mar; 291(1-2):3-10. PubMed ID: 15707726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical properties of antifungal drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques.
    Al-Marzouqi AH; Elwy HM; Shehadi I; Adem A
    J Pharm Biomed Anal; 2009 Feb; 49(2):227-33. PubMed ID: 19062214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
    Srivalli KM; Mishra B
    AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
    Ozdemir N; Ordu S
    Drug Dev Ind Pharm; 1998 Jan; 24(1):19-25. PubMed ID: 15605593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-beta-cyclodextrin.
    Ribeiro A; Figueiras A; Santos D; Veiga F
    AAPS PharmSciTech; 2008; 9(4):1102-9. PubMed ID: 18975116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes.
    Cirri M; Rangoni C; Maestrelli F; Corti G; Mura P
    Drug Dev Ind Pharm; 2005 Aug; 31(7):697-707. PubMed ID: 16207617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.